Unintentional treatment interruptions in diabetic retinopathy patients, especially those with proliferative disease, managed with antivascular endothelial growth factor (anti-VEGF) therapy alone can result in irreversible blindness, as shown in a recent study.
In patients with acute central retinal vein occlusion, a history of systemic hypertension and presenting with worse visual acuity and a relative afferent pupillary defect predict the development of neovascular glaucoma, a retrospective study has shown.
A UK study has recently found that while adalimumab is clinically effective in uveitis associated with juvenile idiopathic arthritis (JIA), its cost-effectiveness compared with methotrexate alone in the UK setting is not demonstrated.
Higher adherence to the Mediterranean Diet (MedDiet) results in a 41-percent reduced risk of incident advanced age-related macular degeneration (AMD), according to pooled data from the Rotterdam Study I (RS-I) and Alienor* Study.
Retinal microvascular signs, while relatively rare, may reflect microvascular pathology in the brain, which potentially leads to dementia and cognitive impairment, according to a recent cross-sectional analysis of the Atherosclerosis Risk in Communities cohort.
Using smartphone cameras for ophthalmic examination may result in variabilities in the objective quantification of conjunctival redness, highlighting the importance of camera calibration, a recent study has found.
It appears that attending cram school for ≥2 h/d increases the risk of children’s incident myopia, which may be caused by greater near visual activity or reduced time outdoors, suggests a recent Taiwan study.
Intravitreal triamcinolone acetonide (ITA) and intravitreal dexamethasone implant (IDI) are better than periocular triamcinolone acetonide (PTA) in the treatment of uveitic macular oedema (ME), with modest increases in risk of intraocular pressure (IOP), suggests a study. Such risk does not significantly differ between intravitreal treatments.
Once-daily dosing of the Rho kinase inhibitor netarsudil is not inferior to twice-daily timolol in terms of lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, while having tolerable adverse events, according to the results of the phase III ROCKET-4 trial.
Transdermal androgen appears beneficial to ageing patients with sex hormone deficiency-associated dry eye, with a recent study showing that short-term treatment relieves both symptoms and signs of the condition, as well as improves quality of life (QOL). These benefits are achieved without increasing the incidence of serious side effects.